Skip to content

Survey study, 2023

Is the uterine fibroid symptom survey a reliable tool for measuring treatment outcomes?

This study validated a survey designed to measure fibroid treatment success, but the abstract does not report whether the validation was successful.

Early or limited evidence Women in India with uterine fibroids who have menstrual and premenstrual symptoms

What they did

Researchers translated the UFS-APR (Uterine Fibroid Indicators and Analysis of Patient Recovery) survey for use in India and tested its reliability, accuracy, validity, and ability to detect changes in fibroid symptoms after treatment.

What they found

The abstract describes what was tested (the survey's reliability, accuracy, validity and responsiveness) but does not state the results of these tests.

What it means for you

This research aimed to create a better way to measure how well fibroid treatment works by asking patients directly. The main limitation is that no actual results are reported in the abstract.

About the study

Original title
Presence and Impact of Uterine Fibroids in Women with Menstrual and Premenstrual Syndrome – A Statistical Analysis
Authors
R. Anuradha, G. Rathi
Journal
International Journal of Membrane Science and Technology
Year
2023
Study design
Survey study
Open access
Yes

Topics